KAREN A DAWES Insider Trading $PDLI PDL BIOPHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KAREN A DAWES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KAREN A DAWES. KAREN A DAWES is Director in PDL BIOPHARMA, INC. ($PDLI) and Director in REPLIGEN CORP ($RGEN) and Director in DEPOMED INC ($DMI) and Director in Vaccitech plc ($VACC).
KAREN A DAWES in PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KAREN A DAWES: Director
Holdings: 2,000 shares
Current Value: $4,420
Latest Transaction: Oct 03 2005
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KAREN A DAWES in PDL BIOPHARMA, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DMI, PDLI, RGEN, VACC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 03 2005 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 27.87 | 3,000 | 83,610 | 3,000 | |
| Jun 10 2005 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 18.28 | 1,000 | 18,280 | 1,000 | |
| Jun 10 2005 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 18.28 | 3,000 | 54,840 | 3,000 | |
| Jun 10 2005 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 18.28 | 3,000 | 54,840 | 3,000 | |
| Jun 10 2005 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 18.28 | 15,000 | 274,200 | 15,000 | |
| May 26 2005 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | M | 13.55 | 2,000 | 27,100 | 250 | |
| May 26 2005 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Buy | M | 13.55 | 2,000 | 27,100 | 2,000 | 0 to 2 K |
| Feb 22 2005 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 17.44 | 3,000 | 52,320 | 3,000 | |
| Jul 26 2004 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 15.30 | 3,000 | 45,900 | 3,000 | |
| Jul 01 2004 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 19.13 | 12,000 | 229,560 | 12,000 | |
| Jul 01 2004 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 19.13 | 3,000 | 57,390 | 3,000 | |
| Nov 26 2003 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 13.55 | 2,250 | 30,488 | 2,250 |
Page: 1